Umed Pharma Lab Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.22 Cr
- Satisfied Charges ₹ 11.44 Cr
- Revenue Growth -6.95%
- Profit Growth -5.25%
- Ebitda 22.54%
- Net Worth 39.37%
- Total Assets 28.54%
About Umed Pharma Lab
Umed Pharma Lab Private Limited (UPLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 May 2012 and has a history of 12 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹17.22 Cr. The company has closed loans amounting to ₹11.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
Udumula Venkateswarlu, Vasundhara Udumula, and Srinivasulu Udumula serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2012PTC081082
-
Company No.
081082
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 May 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Umed Pharma Lab Private Limited offer?
Umed Pharma Lab Private Limited offers a wide range of products and services, including Material Testing Labs & Services, Environmental Testing Services, Industrial Testing Service.
Who are the key members and board of directors at Umed Pharma Lab?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Udumula Venkateswarlu
|
Director | 17-Aug-2017 | Current |
|
Vasundhara Udumula
|
Director | 23-May-2012 | Current |
|
Srinivasulu Udumula
|
Director | 08-Jan-2016 | Current |
Financial Performance of Umed Pharma Lab.
Umed Pharma Lab Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.95% decrease. The company also saw a slight decrease in profitability, with a 5.25% decrease in profit. The company's net worth Soared by an impressive increase of 39.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Umed Pharma Lab?
In 2023, Umed Pharma Lab had a promoter holding of 100.00%. The company had 1 Subsidiary and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Umed Healthcare Private LimitedUdumula Venkateswarlu and Vasundhara Udumula are mutual person
-
Jagore Life Sciences Private LimitedUdumula Venkateswarlu is a mutual person
-
Elena Electronics Pacific Private LimitedUdumula Venkateswarlu is a mutual person
-
Umed Hospitals Private LimitedUdumula Venkateswarlu is a mutual person
Charges (Loans)
₹17.22 Cr
₹11.44 Cr
Charges Breakdown by Lending Institutions
- Others : 15.62 Cr
- Canara Bank : 1.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 May 2024 | Others | ₹8.60 M | Open |
| 10 Oct 2023 | Others | ₹2.61 Cr | Open |
| 11 Apr 2023 | Others | ₹1.90 Cr | Open |
| 27 Dec 2022 | Others | ₹1.07 M | Open |
| 06 Dec 2022 | Others | ₹10.14 Cr | Open |
How Many Employees Work at Umed Pharma Lab?
Umed Pharma Lab has a workforce of 177 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umed Pharma Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umed Pharma Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
